Geode Capital Management LLC Purchases 81,670 Shares of Danaher Corporation $DHR

Geode Capital Management LLC grew its position in shares of Danaher Corporation (NYSE:DHR) by 0.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,726,194 shares of the conglomerate’s stock after purchasing an additional 81,670 shares during the period. Geode Capital Management LLC owned about 1.92% of Danaher worth $2,697,800,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Red Tortoise LLC grew its holdings in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Costello Asset Management INC bought a new position in shares of Danaher in the first quarter worth approximately $41,000. Ramirez Asset Management Inc. purchased a new position in shares of Danaher in the second quarter valued at about $40,000. Mowery & Schoenfeld Wealth Management LLC lifted its holdings in Danaher by 53.8% in the 1st quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock worth $42,000 after buying an additional 71 shares during the period. Finally, Strengthening Families & Communities LLC increased its position in Danaher by 81.4% during the 1st quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock valued at $52,000 after purchasing an additional 114 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.20% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $215.80 on Wednesday. The company has a market capitalization of $152.43 billion, a P/E ratio of 44.49, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $258.23. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a 50 day moving average of $204.36 and a 200 day moving average of $200.64.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the company earned $1.71 EPS. The company’s quarterly revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were issued a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. TD Cowen raised their target price on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 price objective (down previously from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Guggenheim reaffirmed a “buy” rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Finally, Redburn Partners set a $220.00 price objective on shares of Danaher in a research note on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.